Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.
Nenning KH, Gesperger J, Furtner J, Nemc A, Roetzer-Pejrimovsky T, Choi SW, Mitter C, Leber SL, Hofmanninger J, Klughammer J, Ergüner B, Bauer M, Brada M, Chong K, Brandner-Kokalj T, Freyschlag CF, Grams A, Haybaeck J, Hoenigschnabl S, Hoffermann M, Iglseder S, Kiesel B, Kitzwoegerer M, Kleindienst W, Marhold F, Moser P, Oberndorfer S, Pinggera D, Scheichel F, Sherif C, Stockhammer G, Stultschnig M, Thomé C, Trenkler J, Urbanic-Purkart T, Weis S, Widhalm G, Wuertz F, Preusser M, Baumann B, Simonitsch-Klupp I, Nam DH, Bock C, Langs G, Woehrer A. Nenning KH, et al. Among authors: iglseder s. Neurooncol Adv. 2023 Oct 18;5(1):vdad136. doi: 10.1093/noajnl/vdad136. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38024240 Free PMC article.
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A. Neuhauser M, et al. Among authors: iglseder s. Acta Oncol. 2019 Jul;58(7):967-976. doi: 10.1080/0284186X.2019.1599137. Epub 2019 Apr 17. Acta Oncol. 2019. PMID: 30994047
ADC textural features in patients with single brain metastases improve clinical risk models.
Nowosielski M, Goebel G, Iglseder S, Steiger R, Ritter L, Stampfl D, Heugenhauser J, Kerschbaumer J, Gizewski ER, Freyschlag CF, Stockhammer G, Scherfler C. Nowosielski M, et al. Among authors: iglseder s. Clin Exp Metastasis. 2022 Jun;39(3):459-466. doi: 10.1007/s10585-022-10160-z. Epub 2022 Apr 8. Clin Exp Metastasis. 2022. PMID: 35394585 Free PMC article.
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.
Heugenhauser J, Galijasevic M, Mangesius S, Goebel G, Buchroithner J, Erhart F, Pichler J, Widhalm G, Stockhammer G, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Czech T, Surböck B, Urbanic Purkart T, Marosi C, Felzmann T, Nowosielski M. Heugenhauser J, et al. Among authors: iglseder s. Cancers (Basel). 2022 Mar 20;14(6):1579. doi: 10.3390/cancers14061579. Cancers (Basel). 2022. PMID: 35326730 Free PMC article.
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
Iglseder S, Iglseder A, Beliveau V, Heugenhauser J, Gizewski ER, Kerschbaumer J, Stockhammer G, Uprimny C, Virgolini I, Dudas J, Nevinny-Stickel M, Nowosielski M, Scherfler C. Iglseder S, et al. J Neurooncol. 2023 Sep;164(3):711-720. doi: 10.1007/s11060-023-04414-3. Epub 2023 Sep 14. J Neurooncol. 2023. PMID: 37707754 Free PMC article.
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C. Buchroithner J, et al. Among authors: iglseder s. Cancers (Basel). 2018 Oct 5;10(10):372. doi: 10.3390/cancers10100372. Cancers (Basel). 2018. PMID: 30301187 Free PMC article.
Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc.
Bsteh G, Auer M, Iglseder S, Walchhofer LM, Langenscheidt D, Koppi S, Schauer-Maurer G, Stockhammer G, Berger T. Bsteh G, et al. Among authors: iglseder s. Neurol Neuroimmunol Neuroinflamm. 2017 Feb 8;4(2):e323. doi: 10.1212/NXI.0000000000000323. eCollection 2017 Mar. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28210660 Free PMC article. No abstract available.
Diagnostic challenges in meningioma.
Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M, Wick W, Sahm F. Nowosielski M, et al. Among authors: iglseder s. Neuro Oncol. 2017 Nov 29;19(12):1588-1598. doi: 10.1093/neuonc/nox101. Neuro Oncol. 2017. PMID: 28531331 Free PMC article. Review.
28 results